Evaluation of E test for susceptibility testing of Mycobacterium tuberculosis to primary anti tubercular drugs

被引:0
|
作者
Kakkar, N [1 ]
Sharma, M [1 ]
Ray, P [1 ]
Sethi, S [1 ]
Kumar, S [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India
关键词
E test; Mycobacterium tuberculosis; susceptibility;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives :Antimicrobial susceptibility tests for tuberculosis take weeks and delayed therapy can lead to an increase in disease incidence. The E test is a new concept for minimum inhibitory concentrations (MIC) determinations for antimicrobial agents that is based on a predefined antibiotic gradient on a plastic strip calibrated with a continuous logarithmic MIC scale covering 15 two-fold dilutions. The present study was undertaken to evaluate E test strips for susceptibility testing of Mycobacterium tuberculosis. Methods :Twenty five clinical isolates of M. tuberculosis were tested for the four first line antitubercular drugs by E test and were compared with standard proportion method. The inoculum turbidity was adjusted to McFarland 3.0 standard and agar plates (Middle brook 7H11 agar) were inoculated and preincubated (37 degrees C in 7-10% CO,) for 24 h after which time, the E test strips were placed on the agar surface which were incubated under same conditions. The MIC was interpreted as the point at which the ellipse intersected the `E test' strip as described in E test technical guide. Results: Of the 25 strains, susceptibility as determined by both methods for isoniazid (INH), rifampin, ethambutol and streptomycin was found in 22 (88%), 20 (80%), 24 (96%) and 18 (72%) strains respectively. Agreement between E test and proportion method was 96 per cent for INH, 92 per cent for rifampin and 100 per cent for ethambutol and streptomycin each. However, sensitivity could be predicted after 7-10 days by E test and exact MIC could also be determined. Interpretation & conclusions: E test method was found to be rapid, accurate, reliable and easy to perform. It can be employed for routine susceptibility testing for antitubercular drugs.
引用
收藏
页码:168 / 171
页数:4
相关论文
共 50 条
  • [11] Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
    Sanchotene, Karine O.
    von Groll, Andrea
    Ramos, Daniela
    Scholante, Ana B.
    Honscha, Gunther
    Valenca, Mariana
    Scaini, Carlos J.
    da Silva, Pedro E. A.
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2008, 39 (01) : 16 - 20
  • [12] Susceptibility Rates of Pulmonary and Extrapulmonary 229 Mycobacterium tuberculosis Isolates to Major Antituberculous Drugs and Comparison of E test and Standard Proportion Methods
    Yasar, Kadriye Kart
    Sengoz, Gonul
    Pehlivanoglu, Filiz
    Bakar, Mehmet
    Tozalgan, Umit
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2011, 31 (05): : 1132 - 1138
  • [13] Evaluation of BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China
    Zhao, Li-li
    Xia, Qiang
    Lin, Nan
    Liu, Binbin
    Zhao, Xiu-qin
    Liu, Zhiguang
    Wan, Kang-lin
    JOURNAL OF MICROBIOLOGICAL METHODS, 2012, 91 (01) : 212 - 214
  • [14] Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay
    Sethi, S
    Sharma, S
    Sharma, SK
    Meharwal, SK
    Jindal, SK
    Sharma, M
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2004, 120 (05) : 468 - 471
  • [15] Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs
    Coban, AY
    Cihan, CC
    Bilgin, K
    Uzun, M
    Akgunes, A
    Cetinkaya, E
    Durupinar, B
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (04) : 450 - 453
  • [16] Perspectives on Tuberculosis Pathogenesis and Discovery of Anti-Tubercular Drugs
    Ntie-Kang, Fidele
    Yong, Joseph N.
    Owono, Luc C. Owono
    Sippl, Wolfgang
    Megnassan, Eugene
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (30) : 3466 - 3477
  • [17] Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru
    Zully M. Puyén
    David Santos-Lázaro
    Aiko N. Vigo
    Jorge Coronel
    Miriam J. Alarcón
    Vidia V. Cotrina
    David A. J. Moore
    BMC Infectious Diseases, 22
  • [18] Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru
    Puyen, Zully M.
    Santos-Lazaro, David
    Vigo, Aiko N.
    Coronel, Jorge
    Alarcon, Miriam J.
    Cotrina, Vidia V.
    Moore, David A. J.
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [19] Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs
    Gallo, Juliana Failde
    Watanabe Pinhata, Juliana Maira
    Saraceni, Claudia Patara
    de Oliveir, Rosangela Siqueira
    JOURNAL OF MICROBIOLOGICAL METHODS, 2017, 139 : 168 - 171
  • [20] Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs
    Sikri, Kriti
    Duggal, Priyanka
    Kumar, Chanchal
    Batra, Sakshi Dhingra
    Vashist, Atul
    Bhaskar, Ashima
    Tripathi, Kritika
    Sethi, Tavpritesh
    Singh, Amit
    Tyagi, Jaya Sivaswami
    REDOX BIOLOGY, 2018, 15 : 452 - 466